What Skyrizi Treats
- Plaque Psoriasis: For adults and children 6 years and older with moderate-to-severe plaque psoriasis who can benefit from systemic therapy or phototherapy.
- Psoriatic Arthritis: For adults and children 6 years and older with active psoriatic arthritis.
- Crohn’s Disease: For adults with moderately to severely active Crohn’s disease.
- Ulcerative Colitis: For adults with moderately to severely active ulcerative colitis.
How It Works
- Targeted Action: Skyrizi is an interleukin-23 (IL-23) antagonist.
- Reducing Inflammation: It binds to excess IL-23 proteins to help lower the immune system inflammation linked to these chronic conditions.
Possible Side Effects
- Common Reactions: Upper respiratory infections, headache, fatigue, joint pain, and injection site reactions.
- Serious Risks: Increased risk of serious infections, severe allergic reactions (hypersensitivity), and potential liver problems during treatment for inflammatory bowel disease.
- Which condition you are researching Skyrizi for
- Whether you want information on dosage, savings programs, or administration




Reviews
There are no reviews yet.